Abstract
MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Current Medicinal Chemistry
Title:The Roles of MicroRNAs in Atherosclerosis
Volume: 21 Issue: 13
Author(s): Xinjie Lu and Vijay Kakkar
Affiliation:
Keywords: Atherosclerosis, autoantibodies, MicroRNA, Toll-like receptor and inflammatory.
Abstract: MicroRNA (abbr. miRNA) is an endogenous small non-coding RNAs (containing ~22 nucleotides) found in plants and animals, which functions in transcriptional and post-transcriptional regulation of gene expression. These endogenous gene expression inhibitors were primarily described in cancer but recent emerging roles in the regulation of autoimmune inflammation which is thought to be associated with cardiovascular diseases (CVDs), including atherosclerosis known as an autoimmune disease. MiRNA controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ, and plays the roles in endothelial cell (EC), vascular smooth muscle cell (VSMC), and macrophages, and thereby leading to regulate the progression of atherosclerosis. MiRNA modulates several pathways such as lipid uptake and Toll-like receptor (TLR) signaling, implicating an involvement in plaque development. In the present review, we focus on the roles of microRNAs in atherosclerosis through which highlight the therapeutic possibility for the treatment of atherosclerosis.
Export Options
About this article
Cite this article as:
Lu Xinjie and Kakkar Vijay, The Roles of MicroRNAs in Atherosclerosis, Current Medicinal Chemistry 2014; 21 (13) . https://dx.doi.org/10.2174/0929867321666131218100606
DOI https://dx.doi.org/10.2174/0929867321666131218100606 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Celiac Disease: An Emerging Epidemic
Current Nutrition & Food Science The Role of Beta-Blocker in Heart Failure in Adults with Congenital Heart Disease
Reviews on Recent Clinical Trials Cell Therapy for Myocardial Regeneration
Current Molecular Medicine The ACE2-Ang-(1-7)-Mas Axis and Cardioprotection
Current Cardiology Reviews Periodontal Disease and Periodontal Tissue Regeneration
Current Stem Cell Research & Therapy Clinical Features of Scleroderma-Like Disorders: A Challenge for the Rheumatologist
Current Rheumatology Reviews Cardiac and Vascular Impairment in Patients with Mild Psoriasis: A Longitudinal Study
Current Vascular Pharmacology Myocardial Revascularization for the Elderly: Current Options, Role of Off-pump Coronary Artery Bypass Grafting and Outcomes
Current Cardiology Reviews The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress
Current Cardiology Reviews Targeting the Secretory Pathway for Anti-Inflammatory Drug Development
Current Topics in Medicinal Chemistry The Medicinal Chemistry of Genus <i>Aralia</i>
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: Current Therapeutic Options in Cardiomyopathies)
Current Pharmaceutical Design Pathophysiology of Post-Operative Low Cardiac Output Syndrome
Current Vascular Pharmacology Leptin- and Leptin Receptor-Deficient Rodent Models: Relevance for Human Type 2 Diabetes
Current Diabetes Reviews A Survey on Left Ventricle Segmentation Techniques in Cardiac Short Axis MRI
Current Medical Imaging The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction
Drug Design Reviews - Online (Discontinued) The Pentacyclic Triterpenoids in Herbal Medicines and Their Pharmacological Activities in Diabetes and Diabetic Complications
Current Medicinal Chemistry Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Renin Angiotensin System as a Regulator of Cell Volume. Implications to Myocardial Ischemia
Current Cardiology Reviews